INVOcellTM is a treatment option that allows egg fertilization and early embryo development to take place in the woman's body, in vivo, while offering success rates that are comparable to IVF if patients meet certain diagnostic criteria. The costs of INVOcellTM are also lower than IVF. It requires a similar egg stimulation and retrieval process to IVF, but instead of incubating the early egg and embryo in our lab we place an FDA-approved intravaginal culture device into the vagina. This allows the woman to be a natural incubator while the embryos grow. The embryos will then be removed, and an embryo transfer subsequently performed.